Webinars and Sponsored Roundtables — Register Now

Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.

Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, July 21, 2026, 11:00-11:30 AM CT

Learning Objectives:
  • Explain how transparency and manufacturer partnerships improve quality, consistency, and decision-making confidence in specimen management.
  • Evaluate blood collection tubes beyond cost and commodity assumptions, incorporating clinical impact and risk into decision-making.
  • Assess the potential risk points when using a blood collection device that has not been cleared for a specific purpose.

Roundtable presenters Nick Fingland, PhD, PMP, Senior Director, R&D Operations and Science, BD, and Chris Farnsworth, PhD, D(ABCC), Section Head of Clinical Chemistry, Professor of Pathology and Immunology, Washington University School of Medicine.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.

Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center-Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center-Department of Pathology.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

ARTICLES

Working out AI validation and implementation

December 2025—The CAP Artificial Intelligence Committee is developing a guide for laboratories on implementing AI, covering the entire machine learning life cycle. While laboratories can begin using AI now, they must ensure full validation, even for FDA-approved tools, due to potential biases and population drift.

Respiratory season panels, subtypes, and a new Survey

December 2025—The absence of CDC surveillance data due to the government shutdown has created uncertainty about the severity and impact of the current respiratory virus season. While regional public health surveillance provides some insights, concerns remain about the potential for a severe season, exacerbated by vaccine hesitancy and changes in vaccine guidance. 

Privacy, cost, safety—drone use for patient samples

December 2025—Northwestern Medicine Delnor Hospital piloted a program using drones for transporting patient samples and blood products between the hospital and cancer center. The program, using Valqari drones, achieved a 100% success rate in delivering 303 packages without any damage or temperature fluctuations. 

Why and how lab curbed its CBC and diff orders

December 2025—Massachusetts General Hospital implemented a clinical decision support solution to reduce unnecessary CBC and differential orders, particularly for inpatients. The solution involved an interruptive alert that targeted daily, more than daily, and as-needed orders, recommending alternative orders like CBCs without differentials.

LIS vendors, lab experts on standards and stakeholders

December 2025—A roundtable discussion on laboratory information systems (LIS) focused on the application of AI in lab workflows. Participants emphasized the need for AI to be used as a targeted tool to augment human work, highlighting its potential in streamlining documentation, coding, and data extraction. 

AI starting points and stepping stones

Laboratories considering AI-driven workflows should first identify the specific problem they aim to solve and assess if simpler coding solutions are sufficient. While out-of-the-box AI solutions from vendors offer a lower barrier to entry, laboratories must ensure these solutions align with their workflows and validate them in their own environments.

New toxicology testing guidance to come

Two new ADLM documents provide guidance on toxicology testing for emergency departments, replacing a 2003 guideline. The documents address test menus, turnaround times, and the importance of educating ED staff on assay limitations.

In cytopathology, aiming for gender-inclusive care

A recent article in Archives of Pathology & Laboratory Medicine emphasizes the importance of gender-inclusive care in cytopathology laboratories. The authors, members of the CAP Cytopathology Committee, identify four key areas for improvement: laboratory information systems and terminology, cervicovaginal Pap test screening, HPV testing, and anal Pap test screening. They advocate for gender-inclusive data entry, understanding changes from hormonal therapy, equitable access to HPV testing, and expanding anal Pap test screening infrastructure.